Skip to content

Characterization of Obesity-related Cardiomyopathy Through Exploration of Human Atrial Trabeculae Contraction

Characterization of Obesity-related Cardiomyopathy Through Exploration of Human Atrial Trabeculae Contraction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02384252
Enrollment
134
Registered
2015-03-10
Start date
2013-06-03
Completion date
2017-01-19
Last updated
2019-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Obesity

Keywords

obese cardiomyopathy, mitochondria, contractile dysfunction

Brief summary

The investigators aim to explore obese cardiomyopathy by studying contractile twitch force, sarcomere sensitivity to calcium and mitochondrial function in atrial myocardial samples of patients grouped according to their body mass index, i.e. normal weight, overweight and obese.

Detailed description

Obesity is associated with the development of heart failure, regardless of coronary artery disease or other comorbidities. Right atrial samples obtained from patients undergoing cardiac surgery and presenting no sign of clinical cardiomyopathy will be grouped according to patient's body mass index. Atrial trabeculae will be explored to dissect out the respective contribution of (i) sarcoplasmic reticulum dysfunction (isometric twitch force contraction analysis), (ii) abnormal sarcomere sensitivity to calcium assessed in permeabilized fibers and (iii) mitochondrial dysfunction to intrinsec contractile dysfunction of myocardium in obese patients.

Interventions

OTHERfunctional tissu atrial analysis

Sponsors

University Hospital, Lille
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient schedulled for coronary artery bypass graft surgery or aortic valve replacement surgery with extracorporeal circulation * must be over 18 years of age * must be able to read and understand the consent form in French * must be in sinus rhythm at inclusion time

Exclusion criteria

* medical history of type 1 diabetes * medical history of sustained atrial arrhythmia * pregnancy * class III anti-arhythmic drug

Design outcomes

Primary

MeasureTime frameDescription
Intrinsic myocardial contractile forcethe day of cardiac surgerytwitch force developed by atrial trabeculae assessed in isometric conditions in atrial samples

Secondary

MeasureTime frameDescription
sarcomere sensitivity to calciumthe day of cardiac surgeryforce-calcium concentration relation assessed on permeabilized atrial fibers
Mitochondrial functionthe day of cardiac surgeryassesment of mitochondrial respiration and calcium retention capacity by oxygraphic measurement in saponin-permeabilized atrial fibers

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026